Advertisement
Advertisement
U.S. markets close in 3 hours 12 minutes
Advertisement
Advertisement
Advertisement
Advertisement

ContraFect Corporation (CFRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.1772+0.0008 (+0.45%)
As of 12:46PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close0.1764
Open0.1779
Bid0.1771 x 800
Ask0.1772 x 800
Day's Range0.1757 - 0.1829
52 Week Range0.1750 - 4.5400
Volume154,656
Avg. Volume2,389,584
Market Cap6.97M
Beta (5Y Monthly)0.09
PE Ratio (TTM)N/A
EPS (TTM)-0.8950
Earnings DateNov 14, 2022 - Nov 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CFRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ContraFect Corporation
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    7 days agoMorningstar
View more
Advertisement
Advertisement